Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Using brain stimulation to reduce cravings in methamphetamine users

Official title: The Use of Repetitive Transmagnetic Stimulation to Target Craving in Methamphetamine Use Disorder

Run by Oregon Health and Science University · NCT03470480 · Data updated 2026-11-12

This study tests whether a type of brain stimulation can help reduce cravings for methamphetamine in adults who are trying to stay off the drug.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment50 (estimated)
SponsorOregon Health and Science University
Academic / other
Locations1 site (Portland, Oregon)
StatusRecruiting
StartedFebruary 7, 2018
Main results expectedSeptember 1, 2027
Study endsSeptember 1, 2027
Registry record updatedSeptember 23, 2026
Trial IDNCT03470480 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with a history of methamphetamine use disorder who have recently abstained from methamphetamine and are motivated to quit.

Probably not a fit

Patients with significant psychiatric disorders or other substance use disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project investigates the effects of high frequency repetitive transmagnetic stimulation (HF-rTMS) on cue-induced cravings in adults with methamphetamine use disorder. Participants who have recently abstained from methamphetamine will be randomly assigned to receive either real or sham rTMS while being exposed to methamphetamine-related or neutral visual cues. The study aims to determine if stimulation of the left dorsolateral prefrontal cortex can effectively reduce cravings for methamphetamine. The outcomes will be measured using validated craving assessments.

Why it matters

Potential benefit: If successful, this approach could provide a novel non-pharmacological treatment option for individuals struggling with methamphetamine addiction.

How similar studies have gone: While the use of rTMS in addiction treatment is still emerging, preliminary studies have shown promise in reducing cravings for various substances.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Subjects must use at least 0.5 g per day at least 5 days per week and have a minimum 12-month history of METH abuse.
* Subjects must meet DSM V diagnosis for methamphetamine use disorder.
* Subjects must have a minimum 4-week period of detoxification and a desire to stop using methamphetamine.

Exclusion Criteria:

* Present or past history of neurological disorder
* The present history of a DSM IV Axis I or DSM V primary psychiatric disease (apart from MUD and depressive symptoms defined as a Hamilton Depression Scale Score \< 7 ("normal"))
* Scores on the Hamilton Depression Scale \> 8, possibly indicating clinical depression
* No current abuse of drugs other than methamphetamine (except nicotine). Urine-screening tests for psychoactive drugs will be performed to corroborate the lack of drug use.
* Individuals meeting criteria for cannabis use disorder or alcohol use disorder
* Medical illness that can affect brain function
* Past or present history of cardiovascular disease or high blood pressure
* Any history of epilepsy or a known history of seizure disorder
* A history of metal in the head or chest area (except dental fillings or braces)
* Current consumption of psychiatric medication
* Any other medical, neurological or neurosurgical condition that would preclude the administration of repetitive transmagnetic stimulation

Where it's running

  • Veterans Affairs Portland Health Care System
    Portland, Oregon, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.